ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3016 - 3030 of 5448 products
Shanghai's EpimAb Closes $25 Million A Round for Bi-Specifics
$5.00
Available
Aslan to Start Global Phase III Trial of Lead Cancer Drug
$5.00
Available
Zai Lab Acquires China Rights to Novel Antibiotic from Paratek
$5.00
Available
HitGen Enters Drug Discovery Collaboration with Scripps Research Institute
$5.00
Available
Denovo Acquires Global Rights to Depression Drug Candidate
$5.00
Available
Shaanxi Kangui Pharma Completes $52 Million Shanghai IPO
$5.00
Available
BeiGene Starts China Trial of PI-1 Drug in Hodgkin Lymphoma
$5.00
Available
Aire Eye Hospital Offers $166 Million for European Ophthalmology Clinics
$5.00
Available
Qiming's US Fund Leads $25 Million Round for ZappRx
$5.00
Available
Suzhou Ribo Forms Broad ssRNAi Collaboration with Ionis Pharma
$5.00
Available
Antengene Acquires East Asian Rights to Celgene Cancer Candidate
$5.00
Available
Zhejiang POCTech Lands $14.5 Million for Glucose Monitors
$5.00
Available
Qiang Sen International Raises $14.5 Million for Community Clinics
$5.00
Available
Tianjin CanSino Biologics Raises $65 Million for Vaccine Development
$5.00
Available
HitGen Signs Drug Discovery Deal with Pfizer
$5.00
Available